TrialBridgeNCT07741864
Effectiveness of a Mindfulness-Based Intervention for Pain Management in Patients With Multiple Sclerosis (MPIMS).
Not Yet Recruiting · Not Applicable · Hospital Universitario Virgen Macarena · registry updated 2026-08-03
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
The goal of this clinical trial is to evaluate whether a mindfulness-based intervention is effective for reducing pain in adults with multiple sclerosis. It will also assess whether this intervention improves other symptoms commonly associated with pain, such as fatigue, sleep disturbances, anxiety, depression, and quality of life. The main questions it aims to answer are: * Does a mindfulness-based intervention reduce pain intensity in people with multiple sclerosis? * Does the intervention improve fatigue, sleep quality, emotional well-being, quality of life? * Does the effectiveness of the intervention differ according to the type of pain experienced by participants? Researchers will compare a mindfulness-based intervention with an educational program to determine whether mindfulness provides additional benefits for pain management in people with multiple sclerosis. Participants will: * Be randomly assigned to either the mindfulness intervention group or the educational control group. * Complete assessments before the intervention, immediately after the intervention, and at 1-month and 3-month follow-up visits....
Inclusion
- Adults aged 18 to 80 years.
- Diagnosis of multiple sclerosis with an Expanded Disability Status Scale (EDSS) score between 1.0 and 7.0.
- Presence of pain.
- Ability to provide written informed consent.
Exclusion
- Severe cognitive impairment.
- Diagnosed psychiatric disorders (e.g., schizophrenia or personality disorders).
- Participation in another non-pharmacological intervention specifically aimed at pain management.
- If receiving stable pain medication, treatment must have been maintained for at least 4 months before enrollment.
- Unwillingness to provide informed consent.